Evidence map›Paper›PMID 28716159›Full record

ReviewExpert reviews in molecular medicine2017

Bilateral Wilms tumour: a review of clinical and molecular features.

Jocelyn Charlton, Sabine Irtan, Christophe Bergeron, Kathy Pritchard-Jones

Open access · hybridAbstract readReview
In one paragraph

Review in Expert reviews in molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Wilms tumor characteristics in children with heterozygous germline DIS3L2 variants.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  10. A rare case of fetal bilateral Wilms' tumor in horseshoe kidney: A case report.International journal of surgery case reports · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Jocelyn CharltonUCL Institute of Child Health,University College London,London,UK.
Sabine IrtanUCL Institute of Child Health,University College London,London,UK.
Christophe BergeronCentre Léon Bérard,Institut d'Hématologie et d'Oncologie Pédiatrie,Lyon,France.
Kathy Pritchard-JonesUCL Institute of Child Health,University College London,London,UK.
University College London · GBCentre Léon Bérard · FRHôpital Armand-Trousseau · FR

Funding

Cancer Research UK 17297Cancer Research UK C1188/A4614
6 · The paper itself

Abstract

Wilms tumour (WT) is the most common paediatric kidney cancer and affects approximately one in 10 000 children. The tumour is associated with undifferentiated embryonic lesions called nephrogenic rests (NRs) or, when diffuse, nephroblastomatosis. WT or NRs can occur in both kidneys, termed bilateral disease, found in only 5-8% of cases. Management of bilateral WT presents a major clinical challenge in terms of maximising survival, preserving renal function and understanding underlying genetic risk. In this review, we compile clinical data from 545 published cases of bilateral WT and discuss recent progress in understanding the molecular basis of bilateral WT and its associated precursor NRs in the context of the latest radiological, surgical and epidemiological features.

Indexed as

Combined Modality TherapyDiagnostic ImagingDisease SusceptibilityEpigenesis, GeneticGenetic Predisposition to DiseaseHumansKidney Failure, ChronicPhenotypeTreatment OutcomeWilms Tumor

Identifiers

PMID28716159
PMCPMC5687181
OpenAlexW2737162681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.